SCHEMBL10635587

SCHEMBL10635587

N#CC1(c2ccc(-n3ccnc3)nc2)COCCN1CCC(=O)O

nearest known ligand 0.36

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 3/20 0.36
▸ CYP3A4 P08684 3/20 0.36
▸ CYP2D6 P10635 3/20 0.36
▸ CYP2C9 P11712 3/20 0.36
▸ CYP2C19 P33261 3/20 0.36
▸ NAMPT P43490 2/20 0.35
▸ KMT2A Q03164 1/20 0.34
▸ GAA P10253 1/20 0.34
▸ TBXAS1 P24557 2/20 0.33
▸ CD38 P28907 1/20 0.32
▸ EGLN3 Q9H6Z9 1/20 0.32
▸ ALOX5AP P20292 1/20 0.32
▸ CHRM1 P11229 1/20 0.31
▸ LMNA P02545 1/20 0.30
▸ MAPK1 P28482 1/20 0.30
▸ TNF P01375 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10470203 0.80 CYP1A2 (0.35) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL10635580 0.68 MAPT (0.36) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL10549444 0.67 SMN1; SMN2 (0.40) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL10469495 0.65 CYP3A4 (0.54) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL10468430 0.65 CYP1A2 (0.41) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL28823761 0.63 NAMPT (0.52) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL10468098 0.63 ALDH1A1 (0.44) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL10468461 0.62 ALDH1A1 (0.49) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL600477 0.61 CYP3A4 (0.61) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL1461371 0.60 CYP1A2 (0.52) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4783463-A Pyridyl-pyridazinone and pyridyl-pyrazolinone compounds and their use in the treatment of congestive heart failure RORER PHARMACEUTICAL CORPORATION (US) 1988-11-08 — — US disclosed
Send feedback